Prognostic outcomes in advanced breast cancer: the metastasis-free interval is important
Author:
Publisher
Elsevier BV
Subject
Pathology and Forensic Medicine
Reference27 articles.
1. Cancer statistics, 2017;Siegel;CA Cancer J Clin,2017
2. Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor;Chang;Cancer,2003
3. Twenty-years experience with de novo metastatic breast cancer;Cortesi;Int J Cancer,2015
4. Survival differences among women with de novo stage IV and relapsed breast cancer;Dawood;Ann Oncol,2010
5. Trends in survival over the past two decades among white and black patients with newly diagnosed stage IV breast cancer;Dawood;J Clin Oncol,2008
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. microRNAs signature in relapse metastasis and de novo metastasis of breast cancer. A systematic review;Critical Reviews in Oncology/Hematology;2023-08
2. Aggressive local therapy for de novo metastatic breast cancer: Challenges and updates (Review);Oncology Reports;2023-07-14
3. Our clinical experiences in patients with de novo and secondary metastatic breast cancers;Annals of Clinical and Analytical Medicine;2023-04-01
4. Factors Affecting Treatment Outcome of Metastatic Breast Cancer: Single Institution Study;Open Access Macedonian Journal of Medical Sciences;2023-02-13
5. Liquiritigenin Blocks Breast Cancer Progression by Inhibiting Connective Tissue Growth Factor Expression via Up-Regulating miR-383-5p;International Journal of Toxicology;2022-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3